---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-028518"
form_type: "8-K"
ticker: "BIAF"
cik: "0001712762"
company_name: "bioAffinity Technologies, Inc."
filed_at: "2023-08-14T23:59:59+00:00"
generated_at: "2026-06-11T11:46:43.045938+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# bioAffinity Tech Q2 net loss widens to $1.7M; revenue $20k; cash $8.3M

## Summary
- Net loss of $1.7M ($0.20/sh) vs $88k ($0.03/sh) in Q2 2022; SG&A up to $1.4M from $409k.
- Revenue of $20k, up from $1k YoY, including $10k from DOD sales of CyPath Lung.
- Cash and equivalents $8.3M at June 30, 2023, down from $11.4M at Dec 31, 2022.
- AMA issued CPT code for CyPath Lung effective Oct 1, 2023; DOD purchased tests.
- Michael Dougherty appointed CFO; previously CFO of Amazon's Alexa commercial domains.

## SEC filing metadata
- accession: 0001493152-23-028518
- form_type: 8-K
- ticker: BIAF
- cik: 0001712762
- company_name: bioAffinity Technologies, Inc.
- filed_at: 2023-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1712762/000149315223028518/0001493152-23-028518-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1712762/000149315223028518/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-028518
- JSON: https://secwatch.observer/filing/0001493152-23-028518.json
- Plain text: https://secwatch.observer/filing/0001493152-23-028518.txt

## Key facts
- Earnings Releases
  bioAffinity Technologies, Inc. reported second quarter of 2023; three and six months ended June 30, 2023 results: revenue $20,000, net income $1.7 million, EPS $0.20 per share.
  - Period: second quarter of 2023; three and six months ended June 30, 2023
  - Revenue: $20,000
  - Net income: $1.7 million
  - EPS: $0.20 per share
  - Result: reported results
  source text: Revenue for the second quarter of 2023 was $20,000, compared with $1,000 for the prior-year period.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1712762/000149315223028518/0001493152-23-028518-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.